MarketInOut Stock Screener Log In | Sign Up

Vertex Pharmaceuticals Inc

XETRA • Healthcare • Biotechnology • Quote as of 10/30/2026
Vertex Pharmaceuticals Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeXETRA
Market Capitalization122,422 mln
Float253 mln
Earnings Date11/02/2026

EPS

15.06
Robust

P / E

33.30
Overvalued

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.36
Borderline

Relative Strength

98 / 100
Top performer

Debt / Equity

0.10
Very low leverage

Business Description

Founded in 1989 and based in Boston, Massachusetts, Vertex Pharmaceuticals develops and sells medicines for people living with serious and life-altering conditions. The company is best known for its range of approved treatments for cystic fibrosis, and has recently expanded into areas such as sickle cell disease, a hereditary blood disorder, and acute pain management. Vertex also has a broad pipeline of new treatments in development, targeting conditions including kidney disease, Type 1 diabetes, and muscular disorders. Its products reach patients through specialty pharmacies, hospitals, clinics, and drug distributors across the United States and internationally.

Key Fundamentals

EPS15.06
P/E33.30
ROE23.74
RPS44.43
ROIC27.19
ROA17.08
Interest Cover761
EBITDA, mln4,717
EV / EBITDA23.11
EV / EBIT24.07
Revenue, mln10,889
EV / Revenue10.01

Quote Details

Last 501.50
Change 18.5 (3.83%)
Open 490.00
Volume 83
Turnover 41,624
Average Volume 32.19

Financial Ratios

Pre-Tax Profit Margin42
Leverage Ratio1.35
Current Ratio3.19
Price / Book6.52
Price / Tangible Book7.04
Price / Cash Flow31.94
Price / Free Cash Flow35.19
Debt / Equity0.10
Price / Sales10.51
PEG Ratio2.05

Financial Strength

Altman Z-Score13.32
Piotroski F-Score 6 / 9
Beneish M-Score-2.36
Price to Intrinsic Value2.65
Price to Graham Number3.04
Shiller PE Ratio55.49

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.9% 97 / 100   
1 Month 10.17% 88 / 100   
2 Months 17.92% 95 / 100   
6 Months 39.44% 96 / 100   
1 Year 38.36% 91 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog